Bottema C D, Ketterling R P, Ii S, Yoon H S, Phillips J A, Sommer S S
Department of Biochemistry and Molecular Biology, Mayo Clinic/Foundation, Rochester, MN 55905.
Am J Hum Genet. 1991 Oct;49(4):820-38.
We report 31 point mutations in the factor IX gene and explore the relationship between the level of evolutionary conservation of an amino acid and the probability of a mutation causing hemophilia B. From our total sample of 125 hemophiliacs and from those reported by others, we identify 95 independent missense mutations, 94 of which occur at amino acids that are evolutionarily conserved in the available mammalian factor IX sequences. The likelihood of a missense mutation causing hemophilia B depends on whether the residue is also conserved in the factor IX-related proteases: factor VII, factor X, and protein C. Most of the possible missense mutations in generically conserved residues (i.e., those conserved in factor IX and in all the related proteases) should cause disease. In contrast, missense mutations in factor IX-specific residues (i.e., those conserved in human, cow, dog, and mouse factor IX but not in the related proteases) are sixfold less likely to cause disease. Missense mutations at nonconserved residues are 33-fold less likely to cause disease. At least three models are compatible with these observations. A comparison of sequence alignments from four and nine species of factor IX and an examination of the missense mutations occurring at CpG residues suggest a model in which most residues fall on opposite ends of a spectrum. In about 40% of residues, virtually any missense mutation in a minority of the residues will cause disease, while virtually no missense mutations will cause disease in most of the remaining residues. Thus, many of the residues in factor IX are spacers; that is, the main chains are presumably necessary to keep other amino acid interactions in register, but the nature of the side chain is unimportant.
我们报告了因子IX基因中的31个点突变,并探讨了氨基酸的进化保守水平与导致B型血友病的突变概率之间的关系。从我们总共125名血友病患者的样本以及其他人报告的样本中,我们鉴定出95个独立的错义突变,其中94个发生在现有哺乳动物因子IX序列中进化保守的氨基酸处。错义突变导致B型血友病的可能性取决于该残基在与因子IX相关的蛋白酶(即因子VII、因子X和蛋白C)中是否也保守。一般保守残基(即在因子IX和所有相关蛋白酶中都保守的残基)中大多数可能的错义突变都应导致疾病。相比之下,因子IX特异性残基(即在人、牛、狗和小鼠因子IX中保守但在相关蛋白酶中不保守的残基)中的错义突变导致疾病的可能性要低六倍。非保守残基处的错义突变导致疾病的可能性要低33倍。至少有三种模型与这些观察结果相符。对四种和九种因子IX的序列比对进行比较,并检查发生在CpG残基处的错义突变,提示了一种模型,其中大多数残基落在一个谱的两端。在大约40%的残基中,少数残基中的几乎任何错义突变都会导致疾病,而其余大多数残基中的错义突变几乎不会导致疾病。因此,因子IX中的许多残基是间隔物;也就是说,主链大概是保持其他氨基酸相互作用对齐所必需的,但侧链的性质并不重要。